Submit
Search
Submit
Menu

  • Information

  • Figures

  • References

  • Contents

  • Fig. 1.

    View in Article
    Full Image

  • Fig. 2.

    View in Article
    Full Image

  • Fig. 3.

    View in Article
    Full Image

  • [1]Kosanovic M, Jokanovic M, Jevremovic M, Dobric S, Bokonjic D. Maternal and fetal cadmium and selenium status in normotensive and hypertensive pregnancy. Biological Trace Element Research. 2002; 89: 97–103.

  • [2]Easterling TR. Pharmacological management of hypertension in pregnancy. Seminars in Perinatology. 2014; 38: 487–495.

  • [3]Maducolil MK, Al-Obaidly S, Olukade T, Salama H, AlQubaisi M, Al Rifai H. Pre-eclampsia: Incidence, determinants, and pregnancy outcomes from maternity hospitals in qatar: A population-based case-control study. The Journal of Maternal-Fetal & Neonatal Medicine.2022; 35: 7831–7839.

  • [4]Dwarkanath P, Muhihi A, Sudfeld CR, Rani S, Duggan CP, Sando MM, et al. Non-inferiority of low-dose compared to standard high-dose calcium supplementation in pregnancy: study protocol for two randomized, parallel group, non-inferiority trials in India and Tanzania. Trials. 2021; 22: 838.

  • [5]Jain S, Sharma P, Kulshreshtha S, Mohan G, Singh S. The role of calcium, magnesium, and zinc in pre-eclampsia. Biological Trace Element Research. 2010; 133: 162–170.

  • [6]Kyozuka H, Murata T, Fukuda T, Yamaguchi A, Kanno A, Yasuda S, et al. Association between pre-pregnancy calcium intake and hypertensive disorders during the first pregnancy: the Japan environment and children’s study. BMC Pregnancy and Childbirth. 2020; 20: 424.

  • [7]Smolarczyk R, Romejko E, Wójcicka-Jagodzińska J, Czajkowski K, Teliga-Czajkowska J, Piekarski P. Homeostasis of calcium-phosphorus-magnesium in women with pregnancy induced hypertension. Ginekologia Polska. 1996; 67: 488–492.

  • [8]Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. British Medical Journal. 2011; 343: d5928.

  • [9]Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. British Medical Journal. 2003; 327: 557–560.

  • [10]Song F, Gilbody S. Bias in meta-analysis detected by a simple, graphical test. Increase in studies of publication bias coincided with increasing use of meta-analysis. British Medical Journal. 1998; 316: 471.

  • [11]Tong MR. The relationship between serum calcium, magnesium, uric acid levels and pregnancy induced hypertension. Maternal and Child Health Care of China. 2010; 1: 23–24. (In Chinese)

  • [12]Wei J, Wei G, Qin L, Qin Y, Deng H. Analysis of the changes of biochemical indexes in a number of patients with hypertensive disorders in pregnancy. Maternal & Child Health Care of China. 2011; 26: 1953–1954. (In Chinese)

  • [13]Li Y. Relationship between pregnancy induced hypertension and serum calcium and magnesium. Laboratory Medicine and Clinic. 2010; 7: 546. (In Chinese)

  • [14]Zhao Y. Serum calcium, magnesium, nitrogen, creatinine and uric acid in pregnancy-induced hypertension syndrome. Journal of Community Medicine. 2008; 6: 4–5.

  • [15]Yu S, Chen Y, Kan S, Gao H. The clinical significance of serum levels of zinc calcium and magnesium in pregnancy-induced hypertension. Chinese Journal of Difficult and Complicated Cases. 2009; 8: 433–434. (In Chinese)

  • [16]Hao Y. Clinical significance of serum calcium, magnesium in pregnant women and determination of uric acid in pregnancy induced hypertension syndrome. The Journal of Practical Medicine. 2005; 21: 952–953. (In Chinese)

  • [17]Guo LL, Guo SL, Li SX, Zhang SY, Li HX, Niu LH. The study on the relationship between trace elements content in whole blood and hypertensive disorder complicating pregnancy. Chinese Journal of Birth Health & Heredity. 2013; 21: 60–62.

  • [18]Zhao F. Ca, Mg, Cu and Zn contents of the maternal and umbilical cord serum in pregnancy-induced hypertension. Zhonghua Fu Chan Ke Za Zhi. 1989; 24: 212–252. (In Chinese)

  • [19]Kumar N, Singh AK. Maternal serum uric acid and calcium as predictors of hypertensive disorder of pregnancy: A case control study. Taiwanese Journal of Obstetrics & Gynecology. 2019; 58: 244–250.

  • [20]Li Y, Qin H, Zhe R. Correlation of serum calcium ion, D-dimer and uric acid with hypertension during pregnancy. Jilin Medical Journal. 2022; 43: 933–934. (In Chinese)

  • [21]Li XJ. Relationship between serum urea, cystatin C, uric acid, homocysteine, calcium ion, magnesium ion and pregnancy hypertension syndrome. China Modern Doctor. 2020; 58: 148–151. (In Chinese)

  • [22]Zhu S, Huang Y, Zeng Q. Changes of cystatin C, serum calcium and magnesium in patients with pregnancy-induced hypertension and clinical analysis. Journal of Baotou Medical College. 2019; 35: 28–30. (In Chinese)

  • [23]Liu SQ. Preeclampsia pregnant women serum calcium and magnesium ion determination analysis. Health Industry in China. 2012; 9: 108. (In Chinese)

  • [24]Wu MZ, Chen W, Chen XH, Huang YZ, Lu DQ. The value of blood β -chorionic gonadotropin, blood calcium, hematocrit and mean arterial pressure in predicting pregnancy-induced hypertension syndrome. Journal of Chinese General Practice. 2006; 4: 295–296. (In Chinese)

  • [25]Xu J, Zhu T. Relationship between hypertension in pregnancy and changes of serum sodium, calcium and magnesium. Chinese Maternal and Child Health Study. 2011; 22: 819–821. (In Chinese)

  • [26]Liang YB, Huang SY. Relationship of serum chorionic gonadotropin, calcium, uric acid and creatinine levels with PIH. Journal of Chengdu Medical College. 2009; 4: 267–269. (In Chinese)

  • [27]Gu LJ, Wang YK, Hong KT. Investigation and analysis of common serum biochemical indexes of pregnant women with piH in Zhoushan area. China Modern Doctor. 2014; 52: 73–75. (In Chinese)

  • [28]Wang LP, Zi J, Lin LP. The value of urea nitrogen, uric acid and calcium in the diagnosis of PIH. China Tropical Medicine. 2008; 8: 599–600.(In Chinese)

  • [29]Zheng Q, Liu SP, Gou L, Wang X, Wang F. Clinical significance of multiindex detection in patients with gestational hypertension. International Journal of Laboratory Medicine. 2015; 33: 3110–3111, 3114. (In Chinese)

  • [30]Wen X, Hu C, Wang W. Clinical significance of CRP, uric acid and calcium in pregnant women with preeclampsia. Experimental and Laboratory Medicine. 2015; 33: 322–324. (In Chinese)

  • [31]Xie F, Gao G, Zhang C. The expression and clinical significance of serum fasting serum insulin, Ca (2+) and adiponectin in gestational hypertension. Jiangsu Journal of Preventive Medicine. 2020; 31: 145–151. (In Chinese)

  • [32]He L, Lang L, Li Y, Liu Q, Yao Y. Comparison of serum zinc, calcium, and magnesium concentrations in women with pregnancy-induced hypertension and healthy pregnant women: A meta-analysis. Hypertension in Pregnancy. 2016; 35: 202–209.

  • [33]Mahomed K, Williams MA, Woelk GB, Mudzamiri S, Madzime S, King IB, et al. Leukocyte selenium, zinc, and copper concentrations in preeclamptic and normotensive pregnant women. Biological Trace Element Research. 2000; 75: 107–118.

  • [34]Hofmeyr GJ, Betrán AP, Singata-Madliki M, Cormick G, Munjanja SP, Fawcus S, et al. Prepregnancy and early pregnancy calcium supplementation among women at high risk of pre-eclampsia: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2019; 393: 330–339.

  • [35]Sun X, Li H, He X, Li M, Yan P, Xun Y, et al. The association between calcium supplement and preeclampsia and gestational hypertension: a systematic review and meta-analysis of randomized trials. Hypertension in Pregnancy. 2019; 38: 129–139.

  • [36]Gupta S, Jain NP, Avasthi K, Wander GS. Plasma and erythrocyte zinc in pre-eclampsia and its correlation with foetal outcome. The Journal of the Association of Physicians of India. 2014; 62: 306–310.

  • [37]Khaing W, Vallibhakara SA, Tantrakul V, Vallibhakara O, Rattanasiri S, McEvoy M, et al. Calcium and Vitamin D Supplementation for Prevention of Preeclampsia: A Systematic Review and Network Meta-Analysis. Nutrients. 2017; 9: 1141.

  • [38]Ferrazzi E, Zullino S, Stampalija T, Vener C, Cavoretto P, Gervasi MT, et al. Bedside diagnosis of two major clinical phenotypes of hypertensive disorders of pregnancy. Ultrasound in Obstetrics & Gynecology. 2016; 48: 224–231.

Academic Editor

Article Metrics

  • Fig. 1.

    View in Article
    Full Image

  • Fig. 2.

    View in Article
    Full Image

  • Fig. 3.

    View in Article
    Full Image

  • Information

  • Download

  • Contents

Open Access 15 Mar 2023Systematic Review
The Relationship between Serum Calcium Level and Risk Factor of Pregnancy-Induced Hypertension: A Meta-Analysis
Yu-Xin Song 1, Lian-Ping He 1, Cui-Ping Li 1,*
Affiliation
Article Info

1 School of Medicine, Taizhou University, 318000 Taizhou, Zhejiang, China

*Correspondence: lcpyxy@tzc.edu.cn (Cui-Ping Li)

Abstract

Background: The relationship between serum calcium levels and pregnancy-induced hypertension is controversial. This work aimed to evaluate the relationship between serum calcium levels and the risk of pregnancy-induced hypertension. Methods: The following database: Chinese National Knowledge Infrastructure and PubMed, were searched to identify articles on the relationship between serum calcium levels and pregnancy-induced hypertension. The meta-analysis was conducted by using Review Manager (RevMan) [Computer program]. Results: A total of twenty one articles included in the present study. The meta-analysis revealed that patients with pregnancy-induced hypertension (PIH) had lower calcium levels (standardized weighted mean difference (SMD) = –0.68; 95% (–0.79, –0.56); p < 0.05). Conclusions: Our study suggests that serum calcium levels may be associated with the risk of pregnancy-induced hypertension.

Keywords

  • calcium
  • hypertension
  • case-control study
  • meta-analysis
1. Introduction

Pregnancy-induced hypertension (PIH) is a significant cause of maternal morbidity [1, 2]. A previous study disclosed that 5.1% of pregnancies are affected by PIH [3]. Furthermore, approximately 15% of global maternal deaths (~30,000 deaths per year) are attributed to hypertensive disorders of pregnancy [4]. Consequently, the prevention and treatment of PIH in urgent in the present study.

Calcium plays a critical role in many vital processes, such as neuronal excitability, the release of neurotransmitters, muscle contraction, membrane integrity, and blood coagulation [5]. In addition, blood pressure is regulated by intracellular calcium in the vascular smooth muscle cell via vasoconstriction and variations in the vascular volume. Therefore, appropriate calcium intake for pregnant women can prevent future osteoporosis and reduces the risk of PIH [6]. However, results reported in previous studies were inconsistent for the relationship between serum calcium level and PIH [7]. Thus, this meta-analysis must confirm the relationship between serum calcium level and PIH.

Our meta-analysis aimed to determine whether or not serum calcium level levels are associated with the risk of PIH, which will offer the basis for the prevention and treatment of PIH.

2. Methods

This study protocol was followed PRISMA guidelines.

2.1 Literature Search

We searched related articles from the Chinese National Knowledge Infrastructure and PubMed databases until July 12, 2022. The following terms: “calcium”; and “pregnancy hypertension”, was used for articles published. In addition, we also searched the references list of relevant studies selected from the electronic databases manually to find additional articles. The language of papers published is restricted to Chinese and English.

2.2 Inclusion and Exclusion Criteria

The retrieved articles met the following criteria: (1) the study involved humans; (2) the study focused on the relationship between PIH and serum calcium level; (3) data needed was easily extracted directly or indirectly from the article; (4) publication language was confined to English and Chinese.

2.3 Quality Assessment

Two authors evaluated the independently using Newcastle-Ottawa Scale (NOS) [8]. We used NOS to assess non- randomized controlled trial (RCT) studies. It includes three main domains (1) selection (cases and control definition, cases and controls selection) maximum of four stars, (2) comparability (are cases and controls comparable or not) maximum of two stars, (3) exposure (for what degree we are confident that our population exposed to the exposure) maximum three stars.

2.4 Statistical Analysis

The meta-analysis was performed using Review Manager (RevMan) [Computer program] (Version 5.4. The Cochrane Collaboration, 2020, London, UK). The standardized weighted mean difference (SMD) with a corresponding 95% confidence interval (CI) was used to compare the mean serum calcium level between the two groups. Heterogeneity among effect sizes was tested using a Q statistic and an I2 index. The Q statistic tests the null hypothesis that effect sizes are homogeneous in the analysis (Q = 0) [9]. The random effect model was used when the I2 index was over 50%. The funnel plot was applied to detect possible publication bias [10].

3. Results

A total of 21 potential articles were identified in this study (Table 1, Ref. [11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31] and Fig. 1). NOS was used to assess non-RCT studies (Table 1).

Table 1.Characteristics of studies included.
First author year Total Sample types Country NOS
Tong M [11] 2010 90 serum China 9
Wei J [12] 2008 187 serum China 9
Li Y [13] 2010 100 serum China 8
Zhao Y [14] 2008 160 serum China 9
Yu S [15] 2009 142 serum China 8
Hao Y [16] 2005 89 serum China 9
Guo L [17] 2013 118 serum China 9
Zhao, F [18] 1989 212 serum China 9
Kumar N [19] 2019 220 serum India 5
Li YZ [20] 2022 511 serum China 9
Li XJ [21] 2020 166 serum China 9
Zhu SY [22] 2019 290 serum China 9
Liu SQ [23] 2012 80 serum China 9
Wu MZ [24] 2006 218 serum China 9
Xu J [25] 2011 120 serum China 8
Liang YB [26] 2009 133 serum China 9
Gu LJ [27] 2014 110 serum China 9
Wang LP [28] 2008 100 serum China 7
Zheng Q [29] 2015 220 serum China 7
Wen XG [30] 2015 143 serum China 9
Xie F [31] 2020 160 serum China 9

Note: NOS, Newcastle-Ottawa Scale.
Fig. 1.

PRISMA diagram of the search strategy.

The heterogeneity test found heterogeneity exists (I2 index = 95%). Then, a random effect model was used to compare the mean serum calcium level between the two groups. The results indicated that the mean serum calcium level in the PIH group was lower than in the control group (p < 0.05, Fig. 2, Ref. [11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31]).

Fig. 2.

Forest plot and the risk of bias among studies included.

Publication Bias and Sensitivity Analysis

Funnel plots determined publication bias. There was no evidence of publication bias (Fig. 3).

Fig. 3.

Funnel plot and the risk of bias among studies included.

4. Discussion

In this meta-analysis, we discovered that the mean serum calcium level in the PIH group was lower than in the control group. The results are consistent with previous results of meta-analysis [32]. Specifically, the serum calcium levels decreased in patients with PIH according to random effects, consistent with an earlier study [5, 33]. A recent study also confirmed that calcium supplementation could effectively reduce the risk of PIH [34, 35].

In recent years, studies have been carried out on serum trace elements levels during pregnancy. PIH is a pregnancy-specific condition that augments maternal and infant mortality and morbidity [36]. Vitamin D can facilitate the absorption of calcium. Thus, vitamin D supplementation also reduces the risk of PIH. Furthermore, a meta-analysis suggested that vitamin D supplementation also works well in preventing PIH [37]. Therefore, measuring serum calcium levels may be a novel way to monitor the risk of PIH.

5. Strengths and Limitations

The strengths of this study include a comprehensive literature search for all relevant No-RCTs, including the content of ordinary pregnant women and pregnancy hypertension women. In addition, we considered effect moderation by trial location and maternal and intervention characteristics. Finally, we reported a broad range of outcomes and considered core outcomes for pregnancy hypertension.

There are some limitations in our meta-analysis. First, this study included only published articles, and some unpublished articles may need to recruit in the present study. Second, this meta-analysis only searched the articles published in Chinese and English. Therefore, language bias also is not avoided. Third, a subanalysis of different phenotypes of hypertensive disorders of pregnancy should be performed [38]. However, this subanalysis is not possible due to a lack of data.

6. Conclusions

Our research suggests that the reduction in serum calcium concentration may be closely related to PIH. Pregnancy can easily lead to maternal calcium deficiency, increasing blood pressure. Future research should focus on ensuring calcium supplements maintain serum calcium balance and target women with low serum calcium for personalized PIH prevention.

Author Contributions

CPL and LPH made contributions to study conception and design; YXS and LPH participated in data collection; LPH and YXS dedicated to data analysis and interpretation; CPL and YXS involved in the drafting of the manuscript. All authors read and approved the final manuscript.

Ethics Approval and Consent to Participate

Not applicable.

Acknowledgment

Thanks to all the peer reviewers for their opinions and suggestions.

Funding

This study was supported by the 2022 Taizhou University Higher Education Teaching Reform Project (No. 105 and No. 114).

Conflict of Interest

The authors declare no conflict of interest.

References

Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.